Skip to content

Study · Non-randomized trial · n = 36 · 2006

1 result

Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.

Krause BT, Ohlinger R

European journal of obstetrics, gynecology, and reproductive biology22 Dec 2005Cited by 13 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. 1 result from people.

  1. 01HumanNon-randomized trialEfficacy outcome

    All women with polyfollicular development ovulated after triptorelin triggering.

    In plain wordsAll women with multiple developing follicles ovulated after triptorelin triggering.

    Outcome
    Not applicableOvulation after trigger
    Study

    n = 36

    Outcome group
    Sex hormones and fertility · Reproductive and sexual health
    Studied dose
    0.5 mg · subcutaneousAs given in this study (human).

    Source sentences

    Summary
    We could prove ovulation in all women
    2 context sentences
    Summary · context
    Thirty-six women received 0.5mg Triptorelin subcutaneously to trigger the ovulation inducing LH surge.
    Summary · context
    Group (a) received 5 x 1000 IU hCG, group (b) received 5 x 500 IU hCG, and group (c) received 5 x 250 mg progesterone, intramuscularly.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    22 Oct 2026, 02:26 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 18:59 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.